All In Biotech

Drug Trial Radar · NCT07176949

Early-Onset Myopia Intervention Project

Project on Myopia Surveillance and Intervention Services for Preschool Children in Shanghai

Last checked: Nov 20, 2026Latest source record: Sep 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

508

Planned (sponsor's estimate)

Start

Jun 1, 2025

Primary completion

Jun 1, 2027

Study completion May 31, 2028

Sponsor

Lead sponsor
Shanghai Eye Disease Prevention and Treatment CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 16, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 3 years, up to 6 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The prevalence of myopia among children has been increasing year by year, which has become a globle public health issue. Studies have shown that defocusing lenses and atroping eyedrops can control the progression of myopia, but there is little evidence of its efficacy in myopia intervention of young pre-schoolers who will face a greater risk of progression to high myopia later in life. Therefore, this study aims to evaluate the effectiveness and safety of spectacle lenses with highly aspherical lenslets (Essilor's Stellest) , as well as 0.01% and 0.05% low concentration atropine eyedrops in myopia intervention among young children aged 3-6.

Conditions

  • Myopia
  • Pre-myopia

Interventions

  • 0.01% atropine eye dropsDrug

    Participants will use 0.01% atropine eyedrops nightly for myopia control.

  • 0.05% atropine eye dropsDrug

    Participants will use 0.05% atropine eyedrops nightly for myopia control.

  • Spectacle lenses with highly aspherical lensletsDevice

    These are a special type of eyeglass lenses designed primarily to slow down the progression of myopia (nearsightedness) in children. The center of the lens provides a clear correction for distance vision, just like regular glasses. The surrounding area contains hundreds of tiny, invisible, and highly aspherical (complex curved) microlenses. These microlenses create a special optical effect. While the child looks straight ahead clearly, peripheral light rays are focused in front of the retina. This is called "myopic defocus." Research suggests that this myopic defocus signal helps to control the excessive elongation of the eyeball, which is the main cause of myopia getting worse.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in cycloplegic spherical equivalenceTime frame: 2 year

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Eye Disease Prevention and Treatment Center

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.